Impact of neurofibromin on ER-alpha and nuclear speck post-transcriptional gene regulation
神经纤维蛋白对 ER-α 和核斑点转录后基因调控的影响
基本信息
- 批准号:10744501
- 负责人:
- 金额:$ 4.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Alternative SplicingAwardBreast Cancer ModelBreast Cancer PatientBreast Cancer cell lineCancer BiologyCell Cycle RegulationCell LineCell physiologyCellsCharacteristicsDataData AnalysesData SetDiagnostic or Prognostic FactorDiseaseEndocrineEstrogen Receptor alphaEstrogen receptor positiveFellowshipFoundationsGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGlioblastomaGoalsHumanImpairmentInvadedKnowledgeLaboratoriesLinkMalignant NeoplasmsMalignant neoplasm of lungMammary NeoplasmsMass Spectrum AnalysisModelingMolecularMotivationMutateNF1 geneNeoplasm MetastasisNuclearNuclear ProteinOutcomePathway interactionsPhasePlayPost-Transcriptional RegulationPostdoctoral FellowProcessPrognosisProliferatingProtein IsoformsProteinsRNARNA BindingRNA SplicingRNA-Binding ProteinsRNA-Protein InteractionRattusRegulationResearchResearch PersonnelResistanceRoleSelective Estrogen Receptor ModulatorsSignal TransductionSpliced GenesSpliceosomesTechniquesTertiary Protein StructureTherapeuticTherapeutic InterventionTrainingTranscriptTranscription ProcessTranscriptional RegulationTumor Suppressor Genesbiological adaptation to stressbreast cancer progressioncareercrosslinkefficacy evaluationenvironmental stressorepigenomicsfitnessfluorescence imaginggenetic corepressorin vivoinhibitorleukemialoss of functionloss of function mutationmalignant breast neoplasmmutantnext generation sequencingnovelnovel diagnosticsnovel therapeutic interventionnovel therapeuticsoverexpressionposttranscriptionalresponseskillstherapy resistanttranscriptomicstumor progression
项目摘要
PROJECT SUMMARY
Alternative splicing (AS) of transcripts is an essential post-transcriptional process that is instrumental
for numerous cell functions including proliferation, differentiation, and survival. The process of AS is regulated
by RNA binding proteins (RBPs) and their proper nuclear localization and interactions with spliceosome
components which form visibly dense compartments called nuclear specks (NS). The ability for cancer to
hijack and utilize AS by targeting genes involved in EMT, invasion, cell cycle regulation, and transcriptional
control has been described to influence metastatic potential and therapeutic resistance. More recently, it has
been shown that 50% of breast cancers contain overexpression or amplification of at least one RBP which
consequently targets gene transcripts for AS to induce invasive characteristics. Furthermore, a novel function
of estrogen receptor alpha (ERα) recently revealed non-canonical RNA binding of ERα to influence post-
transcriptional regulation and promote cell fitness in response to environmental stressors. Our laboratory,
along with other, recently established a critical link between NF1 and ERα in regulation of ERα signaling. NF1
is a tumor suppressor gene, encoding for the protein neurofibromin, that when mutated drives of a subset of
breast cancers with poor prognosis. These studies have sparked motivation to investigate mechanisms in
which NF1-deficient breast cancers contribute to metastasis and endocrine resistance.
The interaction between neurofibromin and ERα describes neurofibromins ability to act as a co-
repressor of ERα’s transcriptional activity. However, it still remains unknown whether this neurofibromin-ERα
interaction regulates ERα’s post-transcriptional regulation or the importance of neurofibromin localization for
this regulation. The overall goal of my F99 training phase (Aim 1) is to determine the role neurofibromin plays
in ERα post-transcriptional regulation. Specifically, the Aims are 1.1) to define neurofibromin’s impact on ERα
dependent post-transcriptional regulation in NF1 mutant ER+ breast cancer models and 1.2) determine the
efficacy of selective estrogen receptor modulators (SERMs) to impact ERα post-transcriptional regulation in
NF1-deficient cells. The training objectives in the F99 phase will expand my molecular techniques, sequencing,
and data analysis in cancer biology. During my K00 phase (Aim 2) I will define the impact nuclear
neurofibromin has on post-transcriptional regulation through nuclear speck formation and function. NF1-
deficient breast cancer models will be used to determine nuclear speck formation, composition, and post-
transcriptional and gene regulation. The training and data resulting from this fellowship award will establish the
foundation of scientific and professional skills for my career as an independent researcher.
项目摘要
转录物的选择性剪接(alternative splicing,AS)是一种重要的转录后过程
用于许多细胞功能,包括增殖、分化和存活。AS的过程是有规律的
RNA结合蛋白(RBP)及其正确的核定位和与剪接体的相互作用
这些成分形成称为核斑点(NS)的可见致密区室。癌症能够
通过靶向参与EMT、侵袭、细胞周期调控和转录的基因劫持和利用AS,
控制已经被描述为影响转移潜能和治疗抗性。最近,
已经显示50%的乳腺癌含有至少一种RBP的过表达或扩增,
从而靶向AS的基因转录物以诱导侵袭性特征。此外,一个新的功能
雌激素受体α(ERα)的研究最近揭示了ERα的非经典RNA结合影响后
转录调节和促进细胞适应性响应环境应激。我们的实验室,
沿着其他研究,最近在NF 1和ERα之间建立了一个调节ERα信号传导的关键联系。NF1
是一种肿瘤抑制基因,编码神经纤维蛋白,当突变时,
预后不良的乳腺癌。这些研究激发了研究
NF 1缺乏的乳腺癌导致转移和内分泌抵抗。
神经纤维蛋白和ERα之间的相互作用描述了神经纤维蛋白作为一种协同作用的能力。
ERα转录活性的阻遏物。然而,目前尚不清楚这种神经纤维蛋白-ER α
相互作用调节ERα的转录后调节或神经纤维蛋白定位的重要性
这个规定。我的F99训练阶段(目标1)的总体目标是确定神经纤维蛋白所起的作用
在ERα转录后调节中的作用。具体而言,目的是1.1)确定神经纤维蛋白对ERα的影响
NF 1突变ER+乳腺癌模型中的依赖性转录后调节,以及1.2)确定
选择性雌激素受体调节剂(SERM)影响ERα转录后调控在乳腺癌中的作用
NF 1缺陷细胞。在F99阶段的培训目标将扩大我的分子技术,测序,
癌症生物学的数据分析。在我的K 00阶段(目标2),我将定义撞击核
神经纤维蛋白通过核斑点的形成和功能进行转录后调节。NF1-
缺陷乳腺癌模型将用于确定核斑点的形成、组成和后处理。
转录和基因调控。这项研究金提供的培训和数据将建立
作为一名独立研究人员,我的科学和专业技能基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Dischinger其他文献
Patrick Dischinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
NSF Engines Development Award: Utilizing space research, development and manufacturing to improve the human condition (OH)
NSF 发动机发展奖:利用太空研究、开发和制造来改善人类状况(OH)
- 批准号:
2314750 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Cooperative Agreement
NSF Engines Development Award: Building an sustainable plastics innovation ecosystem in the Midwest (MN, IL)
NSF 引擎发展奖:在中西部(明尼苏达州、伊利诺伊州)建立可持续塑料创新生态系统
- 批准号:
2315247 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Cooperative Agreement
NSF Engines Development Award: Creating climate-resilient opportunities for plant systems (NC)
NSF 发动机开发奖:为工厂系统创造气候适应机会 (NC)
- 批准号:
2315399 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Cooperative Agreement
International Partnering Award: Using AI to assess senescence and mitochondrial morphology in calcifying VSMCs
国际合作奖:利用人工智能评估钙化 VSMC 的衰老和线粒体形态
- 批准号:
BB/Y513982/1 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
- 批准号:
EP/Z531480/1 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
- 批准号:
EP/Z531509/1 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
- 批准号:
EP/Z53156X/1 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
- 批准号:
EP/Z531625/1 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
- 批准号:
EP/Z531728/1 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
- 批准号:
EP/Z531844/1 - 财政年份:2024
- 资助金额:
$ 4.82万 - 项目类别:
Research Grant